Author

Yankai Xu

Institutions: Binzhou Medical College Hospital, First Affiliated Hospital of Shantou University Medical College

Observed institutions: Binzhou Medical University, Shandong University, Shantou University, Binzhou Medical College Hospital, First Affiliated Hospital of Shantou University Medical College

ORCID: 0009-0004-8688-3146

Observed ORCIDs: 0009-0004-8688-3146, 0009-0000-1101-5310

OpenAlex ID: A5032484949

PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors

2022 · Yang Zhao, Jizhong Che, et al. · Current Cancer Drug Targets · 16

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder

2017 · Yankai Xu, Ruihua Liu, et al. · International Neurourology Journal · 8

Comprehensive analysis of clinical, pathological, and molecular risk factors affecting the prognosis of patients with glioma

2025 · Yankai Xu, Jiesi Zhou, et al. · Medicine · 1

Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review)

2026 · Hongguo Cui, Jingheng Song, et al. · Molecular Medicine Reports

Rapid Symptom Response Pathway and Hospital Utilization After Radical Cystectomy: A Multicenter Interrupted Time-Series Study

2026 · Zhangcong Lu, Guimei Ji, et al. · Research Square

Total Sanghuangporus vaninii Extract Ameliorates Cisplatin-Induced Glioma Cell Death by Regulating Ferroptosis and Inflammation

2026 · Yankai Xu, Jiesi Zhou, et al. · Dose-Response

Effect of ganglioside combined with hyperbaric oxygen on mild to moderate craniocerebral trauma and its influence on serum NSE and MBP levels

2018 · Yankai Xu, Cheng Luo, et al. · Zhongguo jiceng yiyao

Therapeutic effect of hyperbaric oxygen therapy on patients with severe craniocerebral injury and its influence on serum interleukin-1 beta and interleukin-6 levels

2016 · Yankai Xu, Jin Wu, et al.

Works count: 8

Citation count: 25

H-index: 2

I10-index: 1